Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Suzhou Fengbei Biotech Stock Co's PEG is 1. Suzhou Fengbei Biotech Stock Co's 5-Year TTM EBITDA Growth Rate is 16.22.
Suzhou Fengbei Biotech Stock Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was ¥1.20. Therefore, the Peter Lynch Fair Value for today is ¥19.46.
The historical rank and industry rank for Suzhou Fengbei Biotech Stock Co's Peter Lynch Fair Value or its related term are showing as below:
SHSE:603334'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.53 Med: 2.15 Max: 2.15
Current: 1.53
During the past 6 years, the highest Price to Peter Lynch Fair Value Ratio of Suzhou Fengbei Biotech Stock Co was 2.15. The lowest was 1.53. And the median was 2.15.
SHSE:603334's Price-to-Peter-Lynch-Fair-Value is ranked worse than 61.02% of 59
companies
in the Waste Management industry
Industry Median: 1.29
vs SHSE:603334: 1.53
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Suzhou Fengbei Biotech Stock Co (SHSE:603334) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 16.22 instead of 15 in this case.
Suzhou Fengbei Biotech Stock Co's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
30.18
/
19.46
=
1.55
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Peter Lynch Fair Value Related Terms
Suzhou Fengbei Biotech Stock Co Peter Lynch Fair Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Suzhou Fengbei Biotech Stock Co Peter Lynch Fair Value Chart
SHSE:603334 vs WM, RSG, WCN: Peter Lynch Fair Value Comparison
For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Suzhou Fengbei Biotech Stock Co Price-to-Peter-Lynch-Fair-Value vs Waste Management Industry
For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's Price-to-Peter-Lynch-Fair-Value falls into.
Suzhou Fengbei Biotech Stock Co's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was ¥1.20.
* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of ¥19.46 mean?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a Peter Lynch Fair Value of ¥19.46 as of Sep. 13, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #36 out of 59 companies in the Waste Management industry, placing it in the top 61%.
Is Suzhou Fengbei Biotech Stock Co's Peter Lynch Fair Value too high?
Suzhou Fengbei Biotech Stock Co's current Peter Lynch Fair Value is ¥19.46. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #36 out of 59 companies in the Waste Management industry, which is below the industry midpoint. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's Peter Lynch Fair Value compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #36 out of 59 companies for Peter Lynch Fair Value. This places Suzhou Fengbei Biotech Stock Co in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Waste Management company?
The median Peter Lynch Fair Value among Waste Management companies is 1.29, based on 59 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median Peter Lynch Fair Value is 1.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current Peter Lynch Fair Value is ¥19.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current Peter Lynch Fair Value of ¥19.46. The current Peter Lynch Fair Value is ¥19.46. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current Peter Lynch Fair Value is ¥19.46 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
44GF Score
Get the complete analysis for SHSE:603334
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603334 has been successfully added to your 
